The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c
Open accessAbstract
BACKGROUND: Diabetic peripheral neuropathy (DPN) is one of the most common microvascular complications of diabetes. Glycemic variability could be an independent risk factor for diabetes complications in addition to average glucose. Type 2 diabetes with well-controlled glycosylated hemoglobin A1c (HbA1c) may have different terms of glycemic variability and vascular complication consequences. The aim of the study is to investigate the relationship between glycemic variability and DPN in type 2 diabetes with well-controlled HbA1c (HbA1c < 7.0%). METHODS: 45 type 2 diabetes with well-controlled HbA1c(HbA1c < 7.0%) and with DPN (DM/DPN group) were recruited in the study, and 45 type 2 diabetes with well-controlled HbA1c and without DPN (DM/-DPN group) were set as controls. The two groups were also matched for age and diabetic duration. Blood pressure, body mass index(BMI), insulin sensitivity index (Matsuda index, ISI), total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDLC), and low density lipoprotein cholesterol (LDLC) were tested in the two groups. And all patients were monitored using the continuous glucose monitoring (CGM) system for consecutive 72 hours. The multiple parameters of glycemic variability included the standard deviation of blood glucose (SDBG), mean of daily differences (MODD) and mean amplitude of glycemic excursions (MAGE). RESULTS: The DM/DPN group had a greater SDBG, MODD and MAGE, when compared to the DM/-DPN group (p < 0.05). BMI, TC, and LDLC of DM/DPN group were lower than those of DM/-DPN group (p < 0.05). The patients with hypoglycemia were comparable between the two groups (p > 0.05). Univariate analysis showed DPN was closely associated with BMI (OR 0.82, CI 0.72-0.94, p = 0.005), TC (OR 0.63, CI 0.42-0.93, p = 0.02), LDLC (OR 0.4, CI 0.20-0.80, p = 0.009), SDBG (OR 2.95, CI 1.55-5.61, p = 0.001), MODD (OR 4.38, CI 1.48-12.93, p = 0.008), MAGE (OR 2.18, CI 1.47-3.24, p < 0.001). Multivariate logistic regression analysis showed that MAGE (OR 2.05, CI 1.36-3.09, p = 0.001) and BMI (OR 0.85, CI 0.73-0.99, p = 0.033) were significantly correlating with DPN. Glycemic variability, evaluated by MAGE, was the most significantly independent risk factor for DPN. CONCLUSIONS: There was a close relationship between glycemic variability evaluated by MAGE and DPN in type 2 diabetes with well-controlled HbA1c.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is inconsistency in the relationship between glucose variability and DPN in the literature, and some research indicates that for type 2 DM, glucose variability may be regarded as a marker of beta-cell function rather than direct cause of DPN.37–39”
From Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease (2020) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,095
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y., Hendriksen, S. M., Kusek, J. W., & Lente, F. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,726
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Basevi, V., Mario, S. D., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,058
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Cited by
Sorted by citations
Yapanis, M., James, S., Craig, M. E., O'Neal, D. N., & Ekinci, E. I. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac034 · Cited by 319
The risk factors for diabetic peripheral neuropathy: A meta-analysis
Liu, X., Xu, Y., An, M., & Zeng, Q. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212574 · Cited by 266
Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015
Παπάνας, Ν., & Ziegler, D. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.48 · Cited by 221
Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes
Carlson, A. L., Mullen, D. M., & Bergenstal, R. M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0024 · Cited by 181
Ocular Complications of Diabetes and Therapeutic Approaches
Vieira‐Potter, V. J., Karamichos, D., & Lee, D. J. (2016) · BioMed Research International · doi:10.1155/2016/3801570 · Cited by 179
Mayeda, L., Katz, R., Ahmad, I., Bansal, N., Batacchi, Z., Hirsch, I. B., Robinson, N., Trence, D. L., Zelnick, L., & de Boer, I. H. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000991 · Cited by 162
Glucose variability, HbA1c and microvascular complications
Škrha, J., Šoupal, J., Škrha, J., & Prázný, M. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9347-2 · Cited by 159
Glycemic variability: how to measure and its clinical implication for type 2 diabetes
Umpierrez, G. E., & P. Kovatchev, B. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.09.010 · Cited by 148
Khawaja, N. M., Abu-Shennar, J. A., Saleh, M., Dahbour, S. S., Khader, Y. S., & Ajlouni, K. M. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0309-6 · Cited by 148
HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
Su, J., Zhao, L.-H., Zhang, X., Cai, H.-L., Huang, H., Xu, F., Chen, T., & Wang, X. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0693-0 · Cited by 154
Self-citationContinuous glucose monitoring for the routine care of type 2 diabetes mellitus
Ajjan, R. A., Battelino, T., Cos, X., Del Prato, S., Philips, J.-C., Meyer, L., Seufert, J., & Seidu, S. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00973-1 · Cited by 117
“In cross-sectional studies in the context of microvascular disease in T2DM, CGM-defined glycaemic variability has been linked with deterioration in renal function 45 , diabetic retinopathy 46 and neuropathy 47–50 .”
Jun, J. E., Jin, S., Baek, J.-H., Oh, S. W., Hur, K. Y., Lee, M., Lee, M., & Kim, J. H. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0233-0 · Cited by 111
Ohara, M., Fukui, T., Ouchi, M., Watanabe, K., Suzuki, T., Yamamoto, S., Yamamoto, T., Hayashi, T., Oba, K., & Hirano, T. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.09.025 · Cited by 105
Glycated Hemoglobin (HbA1c) as a Biomarker for Diabetic Foot Peripheral Neuropathy
Casadei, G., Filippini, M., & Brognara, L. (2021) · Diseases · doi:10.3390/diseases9010016 · Cited by 90
He, H., Zheng, S.-W., Xie, Y., Wang, Z., Jiao, S., Yang, F.-R., Li, X.-X., Li, J., & Sun, Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02146-w · Cited by 81
Improvement in Neuropathy Outcomes With Normalizing HbA1c in Patients With Type 2 Diabetes
Ishibashi, F., Taniguchi, M., Kosaka, A., Uetake, H., & Tavakoli, M. (2018) · Diabetes Care · doi:10.2337/dc18-1560 · Cited by 80
Li, F., Zhang, Y., Li, H., Lu, J., Jiang, L., Vigersky, R. A., Zhou, J., Wang, C., Bao, Y., & Jia, W. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108289 · Cited by 69
Lai, Y., Chiu, W.-C., Huang, C., Tsai, N., Wang, H., Lin, W.-C., Cheng, B., Su, Y., Su, C.-M., Hsiao, S.-Y., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00090 · Cited by 70
Miyoshi, A., Yamada, M., Shida, H., Nakazawa, D., Kusunoki, Y., Nakamura, A., Miyoshi, H., Tomaru, U., Atsumi, T., & Ishizu, A. (2016) · Pathobiology · doi:10.1159/000444881 · Cited by 58
Hu, Y.-M., Zhao, L.-H., Zhang, X.-L., Cai, H.-L., Huang, H.-Y., Xu, F., Chen, T., Wang, X.-Q., Guo, A.-S., Li, J.-A., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1546-z · Cited by 57
Self-citationThe conundrum of diabetic neuropathies—Past, present, and future
Ang, L. P., Mizokami‐Stout, K., Eid, S., Elafros, M. A., Callaghan, B. C., Feldman, E. L., & Pop‐Busui, R. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108334 · Cited by 54
Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review
Zhang, X., Yang, X. Q., Sun, B., & Zhu, C. (2021) · Communications Biology · doi:10.1038/s42003-021-02896-3 · Cited by 54
Improvement in Glycemic and Lipid Profiles in Type 2 Diabetics with a 90-Day Ketogenic Diet
Walton, C. M., Perry, K., Hart, R. H., Berry, S. L., & Bikman, B. T. (2019) · Journal of Diabetes Research · doi:10.1155/2019/8681959 · Cited by 59
The impact of glycemic variability on diabetic peripheral neuropathy
Jin, H. Y., Lee, K. A., & Park, T. S. (2016) · Endocrine · doi:10.1007/s12020-016-1005-7 · Cited by 49
Xiong, Q., Lu, B., Ye, H., Wu, X., Zhang, T., & Li, Y. (2015) · European Neurology · doi:10.1159/000441449 · Cited by 48
Teliti, M., Cogni, G., Sacchi, L., Dagliati, A., Marini, S., Tibollo, V., Cata, P. D., Bellazzi, R., & Chiovato, L. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118780808 · Cited by 50
Nerve conduction study of the association between glycemic variability and diabetes neuropathy
Akaza, M., Akaza, I., Kanouchi, T., Sasano, T., Sumi, Y., & Yokota, T. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0371-0 · Cited by 45
Mo, Y., Lu, J., & Zhou, J. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14112 · Cited by 53
Lower body mass index is not of more benefit for diabetic complications
Zhang, Y., Guo, Y., Shen, X., Zhao, F., & Yan, S. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13003 · Cited by 38
Kuroda, N., Kusunoki, Y., Osugi, K., Ohigashi, M., Azuma, D., Ikeda, H., Makino, S., Otsuka, A., Tamada, D., Watanabe, N., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13336 · Cited by 36
Foreman, Y. D., Brouwers, M. C. G. J., Berendschot, T. T. J. M., DONGEN, M. C. J. M. V., Eussen, S. J. P. M., van Greevenbroek, M. M. J., Henry, R. M. A., Houben, A. J. H. M., Kallen, C., Kroon, A. A., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0950-x · Cited by 32
Ajjan, R. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16098 · Cited by 35
Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice
Sakamoto, M. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3556w · Cited by 30
Nozawa, K., Ikeda, M., & Kikuchi, S. (2022) · Drugs - Real World Outcomes · doi:10.1007/s40801-022-00309-3 · Cited by 29
Psoma, O., Makris, M., Tselepis, A. D., & Tsimihodimos, V. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221146808 · Cited by 32
Su, J., Yang, X., Zhang, X., Cai, H.-L., Huang, H., Zhao, L., Xu, F., Chen, T., Cheng, X., Wang, X., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183055 · Cited by 31
Self-citationKohata, Y., Ohara, M., Nagaike, H., Fujikawa, T., Osaka, N., Goto, S., Fukase, A., Kushima, H., Hiromura, M., Terasaki, M., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00772-7 · Cited by 29
Zhang, Y., Shen, X., He, L., Zhao, F., & Yan, S. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108096 · Cited by 28
Wang, Y., Zhao, L., Su, J., Qiao, H., Wang, X., Xu, F., Chen, T., Chen, J., Wu, G., & Wang, X.-Q. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0077-5 · Cited by 27
Self-citationJia, Y., Long, D., Yang, Y., Wang, Q., Wu, Q., & Zhang, Q. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111757 · Cited by 30
Guo, Q., Lu, B., Guo, Z., Feng, Z., Yuan, Y., Jin, X., Zang, P., Gu, P., & Shao, J. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i11.489 · Cited by 24
Chinese clinical guidelines for continuous glucose monitoring (2018 edition)
Bao, Y., Chen, L., Chen, L., Dou, J., Gao, Z., Gao, L., Guo, L., Guo, X., Ji, L., Ji, Q., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3152 · Cited by 23
Glycemic Variability and Diabetic Neuropathy in Young Adults With Type 1 Diabetes
Christensen, M. M. B., Hommel, E. E., Jørgensen, M. E., Fleischer, J., & Hansen, C. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00644 · Cited by 24
Hirsch, I. B., & Verderese, C. A. (2017) · Endocrine Practice · doi:10.4158/ep171962.ra · Cited by 22
Diabetic neuropathy: an insight on the transition from synthetic drugs to herbal therapies
Arora, K., Tomar, P. C., & Mohan, V. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00830-2 · Cited by 26
Glycated albumin indicates peripheral diabetic neuropathy
Wang, N., Guo, C., Han, P., & Li, T. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0900-y · Cited by 20
Yang, Y., Zhao, L., Li, D., Xu, F., Wang, X., Lu, C., Wang, C., Yu, C., Zhang, X., Ning, L.-Y., et al. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00720-w · Cited by 24
Self-citationGouveri, E., & Παπάνας, Ν. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01257-5 · Cited by 22
Hsu, J., Yang, Y., Chuang, S.-L., Huang, K., Lee, J., & Lin, L. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.025438 · Cited by 22
Zhang, H., Chen, Y., Zhu, W., Niu, T., Song, B., Wang, W., Wang, W., & Zhang, H. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01865-5 · Cited by 24
Thakur, M., Evans, B. R., Schindewolf, M., Baumgärtner, I., & Döring, Y. (2021) · Cells · doi:10.3390/cells10071689 · Cited by 20
Hukportie, D. N., Li, F., Zhou, R., Zheng, J., Wu, X., Zou, M., & Wu, X. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13273 · Cited by 16
Sakane, N., Hirota, Y., Yamamoto, A., Miura, J., Takaike, H., Hoshina, S., Toyoda, M., Saito, N., Hosoda, K., Matsubara, M., et al. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13973 · Cited by 18
Naqvi, S. S. Z. H., İmani, S., Hosseinifard, H., Wen, Q., Shahzad, M. N., Ijaz, I., Deng, Y., Guo, M., & Xu, Y. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0453-5 · Cited by 19
Glycemic Status Assessment by the Latest Glucose Monitoring Technologies
Malandrucco, I., Russo, B., Picconi, F., Menduni, M., & Frontoni, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218243 · Cited by 17
Huang, Y., Wang, J., Yang, L., Yue, L., Zhang, L., Zhang, Y., Song, Y., Li, D., & Yang, Z. (2020) · RSC Advances · doi:10.1039/d0ra02036b · Cited by 16
Glucose profiles in obstructive sleep apnea and type 2 diabetes mellitus
Aurora, R. N., Gaynanova, I., Patel, P. S., & Punjabi, N. M. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.04.007 · Cited by 16
Huang, R., Wang, H., Shen, Z., Cai, T., Zhou, Y., Wang, Y., Xia, W., Ding, B., Yan, R., Li, H., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.861131 · Cited by 16
Candidate metabolite markers of peripheral neuropathy in Chinese patients with type 2 diabetes.
Shao, M., Xiang, H., Lü, H., Yin, P., Li, G., Wang, Y., Chen, L., Chen, Q., Zhao, C., Lü, Q., et al. (2022) · PubMed Central · Cited by 15
Evans, M. C., Wade, C., Hohenschurz‐Schmidt, D., Lally, P., Ugwudike, A., Shah, K., Bangerter, N. K., Sharp, D. J., & Rice, A. S. C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.727311 · Cited by 15
Zhang, H., Yang, S., Wang, H., Farooqui, H. F. M., Zhu, W., Niu, T., Zhang, Z., Chen, Y., Huang, L., Zhang, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78828-y · Cited by 17
Yan, P., Zhang, Z., Miao, Y., Xu, Y., Zhu, J., & Wan, Q. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00550-2 · Cited by 14
Thomsen, M. N., Skytte, M. J., Astrup, A. V., Deacon, C. F., Holst, J. J., Madsbad, S., Krarup, T., Haugaard, S. B., & Samkani, A. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.07.002 · Cited by 22
Zhang, C., Tang, M., Lü, X., Zhou, Y., Zhao, W., Liu, Y., Liu, Y., & Guo, X. (2020) · Medicine · doi:10.1097/md.0000000000019374 · Cited by 13
Yu, C., Zhuang, L., Xu, F., Zhao, L.-H., Wang, X., Wang, C., Ning, L.-Y., Zhang, X., Zhang, D., Wang, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.997672 · Cited by 13
Self-citationLixisenatide reduces glycaemic variability in insulin‐treated patients with type 2 diabetes
Umpierrez, G. E., O'Neal, D. N., DIGENIO, A. G., Goldenberg, R., Hernández-Triana, E., Lin, J., Park, C., Renard, É., & Kovatchev, B. P. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12930 · Cited by 13
Leulseged, T. W., & Ayele, B. T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220309 · Cited by 13
Glycemic variability’s impact on painful diabetic peripheral neuropathy in type 2 diabetes patients
Chang, K., Pai, Y., Lin, C., Lee, I., & Chang, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-73472-y · Cited by 17
Mikura, K., Kodama, E., Iida, T., Imai, H., Hashizume, M., Kigawa, Y., Tadokoro, R., Sugisawa, C., Endo, K., Iizaka, T., et al. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13788 · Cited by 10
Hajime, M., Okada, Y., Mori, H., Otsuka, T., Kawaguchi, M., Miyazaki, M., Kuno, F., Sugai, K., Sonoda, S., Tanaka, K., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12680 · Cited by 12
Lee, S., Lee, S., Kim, K. M., & Shin, J. H. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1145470 · Cited by 12
Crumbling Pathogenesis and Biomarkers for Diabetic Peripheral Neuropathy
Chong, Z. Z., & Souayah, N. (2025) · Biomedicines · doi:10.3390/biomedicines13020413 · Cited by 13
Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes
Aronoff, S. L. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1285191 · Cited by 11
Iuchi, H., Sakamoto, M., Matsutani, D., Suzuki, H., Horiuchi, R., & Utsunomiya, K. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0028 · Cited by 11
de Souza, L. R., Debiasi, D., Ceretta, L. B., Simões, P. W. T. D. A., & Tuon, L. (2016) · International Archives of Medicine · doi:10.3823/1936 · Cited by 11
Data-analytically derived flexible HbA1c thresholds for type 2 diabetes mellitus diagnostic
Stranieri, A., Yatsko, A., Jelinek, H. F., & Venkatraman, S. (2015) · Artificial Intelligence Research · doi:10.5430/air.v5n1p111 · Cited by 11
Sonoda, S., Okada, Y., Mori, H., Uemura, F., Sugai, K., Hajime, M., Tanaka, K., Kurozumi, A., Narisawa, M., Torimoto, K., et al. (2018) · Journal of UOEH · doi:10.7888/juoeh.40.11 · Cited by 12
Boscari, F., D’Anna, M., Bonora, B. M., Tresso, S., Cappellari, R., Avogaro, A., Bruttomesso, D., & Fadini, G. P. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01278-6 · Cited by 11
Development of a major amputation prediction model and nomogram in patients with diabetic foot
Chen, Y., Zhuang, J., & Yang, C. (2024) · Postgraduate Medical Journal · doi:10.1093/postmj/qgae087 · Cited by 10
Schein, A. S. O., Corrêa, A. P. S., de Macedo, A. C. P., Dartora, D. R., da Silveira, A. D., Severo, M. D., Casali, K. R., & Schaan, B. D. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102669 · Cited by 10
Yang, J., Zheng, C., Wang, Y., Yang, L., & Liu, L. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s388919 · Cited by 8
Influence of Glucose Fluctuation on Peripheral Nerve Damage in Streptozotocin-Induced Diabetic Rats
Kim, Y. J., Lee, N. Y., Lee, K. A., Park, T. S., & Jin, H. Y. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0275 · Cited by 8
Zhang, W., & Chen, L. (2022) · Brain Sciences · doi:10.3390/brainsci12101328 · Cited by 10
Diffusion tensor imaging of diabetic amyotrophy
Hlis, R., Poh, F., Xi, Y., & Chhabra, A. B. (2019) · Skeletal Radiology · doi:10.1007/s00256-019-03182-4 · Cited by 8
Prevalence of peripheral neuropathy and associated risk factors in children with type 1 diabetes
Singh, I., Reddy, C., Saini, A. G., Dayal, D., Sharawat, I. K., Kasinathan, A., Sachdeva, N. K., Attri, S. V., & Sankhyan, N. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.01.003 · Cited by 8
Anastasiou, G., Liberopoulos, E. N., Tentolouris, N., & Παπάνας, Ν. (2024) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346241240513 · Cited by 7
Zhang, H., Chen, M., Sun, L., Zhu, W., Niu, T., Farooqui, H. F. M., Wang, H., Song, B., Wang, J., & Zhang, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1501323 · Cited by 7
Xu, F., Zhao, L.-H., Wang, X.-H., Wang, C., Yu, C., Zhang, X., Ning, L.-Y., Huang, H., Su, J., & Wang, X. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00795-z · Cited by 7
Self-citationThe correlation of dawn phenomenon with glycemic variability parameters in type 2 diabetes mellitus
Román, G., Bala, C. G., Craciun, C. I., Rusu, A., & Craciun, A. E. (2016) · Revista română de medicină de laborator · doi:10.1515/rrlm-2016-0004 · Cited by 7
Cao, W. J., Zou, J., Gao, M., Huang, J., Li, Y., Li, N., Qian, L., Zhang, Y., Ji, M., & Liu, Y. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108831 · Cited by 8
Glycemic Variability among Older Adults with Type 2 Diabetes
Tong, C. V., Noor, N. M., & Mohamad, M. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000652 · Cited by 6
Morita, M., Sada, K., Hidaka, S., Ogawa, M., & Shibata, H. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14211 · Cited by 9
Žďarská, D. J., Hill, M., Kvapil, M., Piťhová, P., & Brož, J. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0379-3 · Cited by 6
Chiang, J., Manski-Nankervis, J.-A. E., Thuraisingam, S., Jenkins, A. J., O'Neal, D. N., Mair, F. S., Jani, B., Nicholl, B. I., & Furler, J. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108451 · Cited by 6
Khan, A. H., Iqbal, M. Z., Sulaiman, S. A. S., Ibrahim, A., Azmi, N. S. B. Y., Iqbal, M. S., & Albassam, A. A. (2020) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_475_20 · Cited by 6
Huang, Q., Cui, M., Yin, Y., Hui, C., Cheng, Y., Wang, S., Hu, X., Yin, X., Zhang, X., Sun, X., et al. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05616-8 · Cited by 5
Assessment of Interday Glucose Variability in Type 2 Diabetes
Dadlani, V., & Kudva, Y. C. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0255 · Cited by 5
Ten, T., Dzed, L., Thinley, S., Tshomo, D., Dechen, K., Mo, Z., Mongar, D. B., Palzang, T., Yangzom, K., Gyeltshen, T., et al. (2016) · Public Health of Indonesia · doi:10.36685/phi.v2i3.76 · Cited by 5
Glycemic Key Metrics and the Risk of Diabetes-Associated Complications
Kohnert, K., Heinke, P., Zander, E., Vogt, L., & Salzsieder, E. (2016) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2016-0047 · Cited by 5
Omirah, M. H. A., Kamal, M., Gomaa, M., Ewais, A. A., AlRasheed, H. A., Bahaa, M. M., Thabet, S., Moawad, H. M., & Magdy, M. M. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00198 · Cited by 4
Metadata
- Authors
- Xu, F., Zhao, L.-H., Su, J.-B., Chen, T., Wang, X.-Q., Chen, J.-F., Wu, G., Jin, Y., & Wang, X.-H.
- Affiliations
- Nantong University (CN)
- Venue
- Diabetology & Metabolic Syndrome
- Published
- 2014-12
- Volume
- 6
- Issue
- 1
- Pages
- 139-139
- ISSN
- 1758-5996 (ISSN-L)
- PMC
- PMC4272789
- OpenAlex
- W2157110135
- Cited by
- 159
- References
- 41
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 21 · 2023: 9 · 2022: 21 · 2021: 15 · 2020: 18 · 2019: 14 · 2018: 15 · 2017: 10 · 2016: 11 · 2015: 5
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Diabetology & Metabolic Syndrome (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- glycemic variability, diabetic peripheral neuropathy, type 2 diabetes, HbA1c control, continuous glucose monitoring, mean amplitude of glycemic excursions, mean of daily differences, body mass index, total cholesterol, LDL cholesterol, insulin sensitivity, hypoglycemia, microvascular complications, glycemic control
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
